Aquestive Therapeutics, Inc. (AQST) Insider Ownership

Historic Ownership Trends

Over the 90-day window ending January 02, 2026, Aquestive Therapeutics's three dominant insider ownership positions are held by Chief Operating Officer Cassie Jung (310.35K shares), Chief People Officer Peter E. Boyd (288.32K shares), Chief Medical Officer Carl N Kraus (282.48K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Alexander Mark Schobel Chief Innovation/Tech Officer 984,476 19 Mar, 2024
Daniel Barber President And Ceo 923,430 29 Sep, 2025
Keith J Kendall Ceo And President 637,149 27 Aug, 2021
Lori J Braender Chief Legal Officer 402,981 11 Mar, 2025
Stephen Wargacki Chief Science Officer 343,552 11 Mar, 2025
A Ernest Jr Toth Chief Financial Officer 339,366 11 Mar, 2025
Cassie Jung Chief Operating Officer 310,346 17 Oct, 2025
Peter E. Boyd Chief People Officer 288,323 05 Dec, 2025
Carl N Kraus Chief Medical Officer 282,475 17 Oct, 2025
Douglas K Bratton 212,426 16 Mar, 2021
Melina Cioffi Svp And Regulatory Affairs 200,178 04 Dec, 2025
Sherry Korczynski Chief Commercial Officer 181,858 15 Aug, 2025
Ken W. Marshall Svp And Chief Commercial Officer 150,000 09 Mar, 2023
John Cochran 99,486 01 Jun, 2021
Matthew W. Davis Chief Development Officer 50,000 12 Nov, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
04 Dec, 2025 Peter E. Boyd Common Stock A 20,000 $0.00 288,323 D A
02 Dec, 2025 Melina Cioffi Common Stock D 2,083 $5.93 200,178 D F
10 Nov, 2025 Matthew W. Davis Common Stock A 50,000 $0.00 50,000 D A
15 Oct, 2025 Cassie Jung Common Stock A 25,000 $3.10 2,000 I M
15 Oct, 2025 Carl N Kraus Common Stock D 20,272 $7.00 282,475 D S
15 Oct, 2025 Peter E. Boyd Common Stock D 10,000 $7.00 268,323 D S
15 Oct, 2025 Cassie Jung Common Stock D 67,575 $7.01 308,346 D S
26 Sep, 2025 Daniel Barber Common Stock D 91,343 $6.03 923,430 D S
26 Sep, 2025 Peter E. Boyd Common Stock D 10,000 $6.30 278,323 D S
19 Sep, 2025 Daniel Barber - - 1,014,773 D
19 Sep, 2025 Daniel Barber Common Stock D 400 $6.00 1,014,773 D S
05 Sep, 2025 Peter E. Boyd Common Stock D 15,000 $5.30 288,323 D S
04 Sep, 2025 Cassie Jung Common Stock A 25,000 $3.15 2,000 I M
04 Sep, 2025 Cassie Jung Common Stock A 25,000 $0.71 320,526 D M
04 Sep, 2025 Cassie Jung Common Stock D 62,180 $5.00 345,526 D S
14 Aug, 2025 Sherry Korczynski Common Stock A 25,000 $0.00 181,858 D A
14 Aug, 2025 Sherry Korczynski - - 181,858 D
09 Aug, 2025 Carl N Kraus Common Stock D 10,819 $3.90 302,747 D F
09 Jun, 2025 Sherry Korczynski Common Stock D 2,714 $3.54 156,858 D F
15 May, 2025 Melina Cioffi Common Stock A 20,000 $0.00 202,261 D A